CD274 and breast carcinoma: The results showed that iBody 1 has similar sensitivity and specificity in staining of cell lines as the α-hPD-L1 antibodies with U251 glioblastoma and MDA-MB-231 breast cancer cell lines showing PD-L1 expression as expected.